Levitz Michael L bought ANIK
March 11, 2024 · Form 4 insider transaction
Levitz Michael L bought 4,438 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,438
Price
$0.00
Total value
N/A
InsiderLevitz Michael L
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 11, 2024
Filing dateMarch 12, 2024
Shares owned after37,830
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.; Includes 160 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.